A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.
- DOI
- 10.1007/s10637-019-00825-0
- Published
- 2019 Dec
- Container
- Investigational new drugs
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10637-019-00825-0,
title = {A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.},
author = {Capriotti KD and Anadkat M and Choi J and Kaffenberger B and McLellan B and Barone S and Kukoyi O and Goldfarb S and Lacouture M},
year = {2019},
journal = {Investigational new drugs},
doi = {10.1007/s10637-019-00825-0},
url = {https://doi.org/10.1007/s10637-019-00825-0}
}RIS
TY - JOUR TI - A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia. AU - Capriotti KD AU - Anadkat M AU - Choi J AU - Kaffenberger B AU - McLellan B AU - Barone S AU - Kukoyi O AU - Goldfarb S AU - Lacouture M PY - 2019 JO - Investigational new drugs DO - 10.1007/s10637-019-00825-0 UR - https://doi.org/10.1007/s10637-019-00825-0 ER -
APA
KD, C., M, A., J, C., B, K., B, M., S, B., O, K., S, G., & M, L. (2019). A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.. Investigational new drugs. https://doi.org/10.1007/s10637-019-00825-0
Source records
- pubmed · retrieved 2026-09-27T10:13:03.009Z